North America is the largest Drug Abuse Treatment market with about 48% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Indivior, Pfizer, Alkermes, Novartis, Mylan, Cipla, Glenmark, Dr. Reddy's Laboratories, Teva Pharmaceutical, PLIVA (Odyssey) etc. Top 5 companies occupied about 14% market share.
Market Analysis and Insights: Global Drug Abuse Treatment Market
The global Drug Abuse Treatment market size is projected to reach US$ 26660 million by 2027, from US$ 17750 million in 2020, at a CAGR of 6.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Abuse Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Abuse Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Abuse Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Abuse Treatment market.
Drug Abuse Treatment Breakdown Data by Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Drug Abuse Treatment Breakdown Data by Application
Hospital & Clinics
Residential (non-hospital)
Based on regional and country-level analysis, the Drug Abuse Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Drug Abuse Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
PLIVA (Odyssey)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Abuse Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Opioid Addiction
1.2.3 Tobacco/Nicotine Addiction
1.2.4 Alcohol Dependence
1.3 Market by Application
1.3.1 Global Drug Abuse Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Residential (non-hospital)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drug Abuse Treatment Market Perspective (2016-2027)
2.2 Drug Abuse Treatment Growth Trends by Regions
2.2.1 Drug Abuse Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Abuse Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Drug Abuse Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Drug Abuse Treatment Industry Dynamic
2.3.1 Drug Abuse Treatment Market Trends
2.3.2 Drug Abuse Treatment Market Drivers
2.3.3 Drug Abuse Treatment Market Challenges
2.3.4 Drug Abuse Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Abuse Treatment Players by Revenue
3.1.1 Global Top Drug Abuse Treatment Players by Revenue (2016-2021)
3.1.2 Global Drug Abuse Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Drug Abuse Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Abuse Treatment Revenue
3.4 Global Drug Abuse Treatment Market Concentration Ratio
3.4.1 Global Drug Abuse Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Treatment Revenue in 2020
3.5 Drug Abuse Treatment Key Players Head office and Area Served
3.6 Key Players Drug Abuse Treatment Product Solution and Service
3.7 Date of Enter into Drug Abuse Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Abuse Treatment Breakdown Data by Type
4.1 Global Drug Abuse Treatment Historic Market Size by Type (2016-2021)
4.2 Global Drug Abuse Treatment Forecasted Market Size by Type (2022-2027)
5 Drug Abuse Treatment Breakdown Data by Application
5.1 Global Drug Abuse Treatment Historic Market Size by Application (2016-2021)
5.2 Global Drug Abuse Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Drug Abuse Treatment Market Size (2016-2027)
6.2 North America Drug Abuse Treatment Market Size by Type
6.2.1 North America Drug Abuse Treatment Market Size by Type (2016-2021)
6.2.2 North America Drug Abuse Treatment Market Size by Type (2022-2027)
6.2.3 North America Drug Abuse Treatment Market Size by Type (2016-2027)
6.3 North America Drug Abuse Treatment Market Size by Application
6.3.1 North America Drug Abuse Treatment Market Size by Application (2016-2021)
6.3.2 North America Drug Abuse Treatment Market Size by Application (2022-2027)
6.3.3 North America Drug Abuse Treatment Market Size by Application (2016-2027)
6.4 North America Drug Abuse Treatment Market Size by Country
6.4.1 North America Drug Abuse Treatment Market Size by Country (2016-2021)
6.4.2 North America Drug Abuse Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Drug Abuse Treatment Market Size (2016-2027)
7.2 Europe Drug Abuse Treatment Market Size by Type
7.2.1 Europe Drug Abuse Treatment Market Size by Type (2016-2021)
7.2.2 Europe Drug Abuse Treatment Market Size by Type (2022-2027)
7.2.3 Europe Drug Abuse Treatment Market Size by Type (2016-2027)
7.3 Europe Drug Abuse Treatment Market Size by Application
7.3.1 Europe Drug Abuse Treatment Market Size by Application (2016-2021)
7.3.2 Europe Drug Abuse Treatment Market Size by Application (2022-2027)
7.3.3 Europe Drug Abuse Treatment Market Size by Application (2016-2027)
7.4 Europe Drug Abuse Treatment Market Size by Country
7.4.1 Europe Drug Abuse Treatment Market Size by Country (2016-2021)
7.4.2 Europe Drug Abuse Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Treatment Market Size (2016-2027)
8.2 Asia-Pacific Drug Abuse Treatment Market Size by Type
8.2.1 Asia-Pacific Drug Abuse Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Abuse Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Abuse Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Abuse Treatment Market Size by Application
8.3.1 Asia-Pacific Drug Abuse Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Abuse Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Abuse Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Abuse Treatment Market Size by Region
8.4.1 Asia-Pacific Drug Abuse Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Abuse Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drug Abuse Treatment Market Size (2016-2027)
9.2 Latin America Drug Abuse Treatment Market Size by Type
9.2.1 Latin America Drug Abuse Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Drug Abuse Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Drug Abuse Treatment Market Size by Type (2016-2027)
9.3 Latin America Drug Abuse Treatment Market Size by Application
9.3.1 Latin America Drug Abuse Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Drug Abuse Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Drug Abuse Treatment Market Size by Application (2016-2027)
9.4 Latin America Drug Abuse Treatment Market Size by Country
9.4.1 Latin America Drug Abuse Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Drug Abuse Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Treatment Market Size (2016-2027)
10.2 Middle East & Africa Drug Abuse Treatment Market Size by Type
10.2.1 Middle East & Africa Drug Abuse Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Abuse Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Abuse Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Abuse Treatment Market Size by Application
10.3.1 Middle East & Africa Drug Abuse Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Abuse Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Abuse Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Abuse Treatment Market Size by Country
10.4.1 Middle East & Africa Drug Abuse Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Abuse Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Indivior
11.1.1 Indivior Company Details
11.1.2 Indivior Business Overview
11.1.3 Indivior Drug Abuse Treatment Introduction
11.1.4 Indivior Revenue in Drug Abuse Treatment Business (2016-2021)
11.1.5 Indivior Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drug Abuse Treatment Introduction
11.2.4 Pfizer Revenue in Drug Abuse Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Alkermes
11.3.1 Alkermes Company Details
11.3.2 Alkermes Business Overview
11.3.3 Alkermes Drug Abuse Treatment Introduction
11.3.4 Alkermes Revenue in Drug Abuse Treatment Business (2016-2021)
11.3.5 Alkermes Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Abuse Treatment Introduction
11.4.4 Novartis Revenue in Drug Abuse Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Drug Abuse Treatment Introduction
11.5.4 Mylan Revenue in Drug Abuse Treatment Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Drug Abuse Treatment Introduction
11.6.4 Cipla Revenue in Drug Abuse Treatment Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Glenmark
11.7.1 Glenmark Company Details
11.7.2 Glenmark Business Overview
11.7.3 Glenmark Drug Abuse Treatment Introduction
11.7.4 Glenmark Revenue in Drug Abuse Treatment Business (2016-2021)
11.7.5 Glenmark Recent Development
11.8 Dr. Reddy's Laboratories
11.8.1 Dr. Reddy's Laboratories Company Details
11.8.2 Dr. Reddy's Laboratories Business Overview
11.8.3 Dr. Reddy's Laboratories Drug Abuse Treatment Introduction
11.8.4 Dr. Reddy's Laboratories Revenue in Drug Abuse Treatment Business (2016-2021)
11.8.5 Dr. Reddy's Laboratories Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Drug Abuse Treatment Introduction
11.9.4 Teva Pharmaceutical Revenue in Drug Abuse Treatment Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development
11.10 PLIVA (Odyssey)
11.10.1 PLIVA (Odyssey) Company Details
11.10.2 PLIVA (Odyssey) Business Overview
11.10.3 PLIVA (Odyssey) Drug Abuse Treatment Introduction
11.10.4 PLIVA (Odyssey) Revenue in Drug Abuse Treatment Business (2016-2021)
11.10.5 PLIVA (Odyssey) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
